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Severe hypercholesterolaemia with 
a high risk of atherosclerosis may be 
precipitated by a high-sterol diet
To the Editor: Increasing dietary fat intake impacts variably on the 
plasma lipid profile, and the consequent dyslipidaemia influences 
cardio vascular risk from atherosclerosis. For most patients, 
cardiovascular risk can be calculated as advised in the South 
African (SA) guideline for dyslipidaemia,[1] but inherited disorders 
carry much higher risk than so calculated. Monogenic disorders 
causing low-density lipoprotein cholesterol (LDL-C) concentrations 
>5  mmol/L, such as heterozygous familial hypercholesterolaemia 
(FH) or homozygous FH with LDL-C concentrations >13 mmol/L, 
confer much higher risk. In untreated heterozygous and homozygous 
FH, coronary artery disease events typically occur in the 5th decade 
and 2nd decade, respectively. These disorders require medication 
regardless of the risk calculation. Uncommonly, persons with 
moderate hypercholesterolaemia (LDL-C 3 - 5 mmol/L) or with more 
severe LDL hypercholesterolaemia can respond to dietary alterations 
with marked increases of LDL concentration due to underlying 
genetic defects. One of these disorders is phytosterolaemia, in which 
hypercholesterolaemia coexists with an elevated plasma plant sterol 
concentration. This serious condition caused fatal atherosclerosis 
in a teenager.[2] Phytosterolaemia responds well to dietary sterol 
restriction and ezetimibe but poorly to statin treatment. We wish to 
draw attention to this disorder because a high-fat diet that included 
much plant sterol precipitated severe hypercholesterolaemia in a 
patient.
A white male developed diabetes mellitus that has been controlled 
well by insulin injections since the age of 14 years. His father 
has severe hypercholesterolaemia with premature vascular disease 
and his mother is also treated for hypercholesterolaemia. Her 
mother had premature coronary artery disease. At 22 years of age 
the patient became a triathlete. He is muscular in appearance, 
lacks stigmata of dyslipidaemia and has a body mass index of 
26.5 kg/m2. His triglyceride and high-density lipoprotein cholesterol 
concentrations are unremarkable. He had an elevated LDL-C 
concentration of 6.1 mmol/L for which simvastatin (20 mg at night) 
was prescribed on suspicion of FH; however, it was discontinued 
because there was a poor response (LDL-C 5.2 mmol/L). To improve 
athletic performance, he adopted a high-fat diet. Intake of eggs 
as well as seeds and nuts increased.  An LDL-C concentration 
of 13.0 mmol/L was recorded. There were no secondary causes 
of hypercholesterolaemia. Non-invasive computed tomography 
coronary angiography revealed no coronary artery calcium and there 
was no evidence of soft plaque. Phytosterolaemia was suspected. 
Reducing dietary sterol intake together with ezetimibe (10 mg 
daily) lowered the LDL-C concentration by 71% to 3.8 mmol/L. 
Phytosterolaemia was confirmed by gas chromatography.
Hypercholesterolaemia suggestive of FH is not rare and occurs at a 
high prevalence in several communities in SA. Hypercholesterolaemia 
due to FH responds well to statins. Phytosterolaemia is rare 
and may result in severe to extreme hypercholesterolaemia and 
atherosclerosis on a sterol-rich diet, especially one containing much 
plant sterols. Phytosterolaemia responds well to dietary modification 
and ezetimibe. In view of the gravity of FH and phytosterolaemia, we 
recommend that plasma cholesterol and triglyceride measurements 
should be done before as well as after embarking on a high-fat 
diet, to ensure that high cardiovascular risk receives appropriate 
attention.
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